Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Clinical trial NCT00524784 · UNKNOWN

Trial details

NCT number: NCT00524784
Sponsor: Hadassah Medical Organization
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Hematological Malignancies

Start date: 2009-06-01
Primary completion: 2012-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.